microrna microarray analysis (Agilent technologies)
Structured Review
Microrna Microarray Analysis, supplied by Agilent technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/microrna+microarray+analysis/pmc09151726-45-1-0
Average 90 stars, based on 1 article reviews
Images
Related Articles
Microarray:Article Title: Progress of exosome research in systemic lupus erythematosus Article Snippet: .. Article Title: Unidirectional transfer of microRNA-loaded exosomes from T cells to antigen-presenting cells Article Snippet: .. Article Title: Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer Article Snippet: .. Plasma samples of 3 EGFR exon 19 deletion, 3 EGFR p.L858R mutation, and 3 EGFR wild-type patients and 4 healthy controls were selected for Derivative Assay:Article Title: Progress of exosome research in systemic lupus erythematosus Article Snippet: .. Clinical Proteomics:Article Title: Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer Article Snippet: .. Plasma samples of 3 EGFR exon 19 deletion, 3 EGFR p.L858R mutation, and 3 EGFR wild-type patients and 4 healthy controls were selected for Mutagenesis:Article Title: Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer Article Snippet: .. Plasma samples of 3 EGFR exon 19 deletion, 3 EGFR p.L858R mutation, and 3 EGFR wild-type patients and 4 healthy controls were selected for Expressing:Article Title: Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer Article Snippet: .. Plasma samples of 3 EGFR exon 19 deletion, 3 EGFR p.L858R mutation, and 3 EGFR wild-type patients and 4 healthy controls were selected for Gene Expression:Article Title: Circulating plasma microRNAs as potential markers to identify EGFR mutation status and to monitor epidermal growth factor receptor-tyrosine kinase inhibitor treatment in patients with advanced non-small cell lung cancer Article Snippet: .. Plasma samples of 3 EGFR exon 19 deletion, 3 EGFR p.L858R mutation, and 3 EGFR wild-type patients and 4 healthy controls were selected for |


